|
|
Respirerx Pharmaceuticals Inc (RSPI) |
|
|
|
Respirerx Pharmaceuticals Inc 's Quick Ratio
RSPI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth
Regardless of the sequential decrease in Current Liabilities, during the second quarter 2023, Quick Ratio deteriorated to 0 a new company low.
Within Major Pharmaceutical Preparations industry 545 other companies have achieved higher Quick Ratio than Respirerx Pharmaceuticals Inc in second quarter 2023. While Quick Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 4571 to 4986.
Explain Quick Ratio?
How much Cash & cash equivalents RSPI´s has?
What are RSPI´s Current Liabilities?
Select the Comparisons :
|
|
Select the Ratio:
|
|
RSPI Quick Ratio |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
(Jun 30 2022) II. Quarter |
Y / Y Current Liabilities Change |
11.25 % |
14.76 % |
18.21 % |
22.68 % |
22.5 % |
Y / Y Cash & cash equivalent Change |
34761.9 % |
-45.24 % |
-93.71 % |
-89.21 % |
-99.93 % |
Quick Ratio MRQ |
0 |
0 |
0 |
0 |
0 |
RSPI's Total
Ranking |
# 4986 |
# 4571 |
# 5449 |
# 5082 |
# 5140 |
Seq. Current Liabilities Change |
-0.63 % |
4.76 % |
2.55 % |
4.21 % |
2.5 % |
Seq. Cash & cash equivalent Change |
5205.07 % |
56.82 % |
46.67 % |
185.71 % |
-91.67 % |
Quick Ratio second quarter 2023 Company Ranking |
Within: |
No. |
Major Pharmaceutical Preparations Industry |
# 546 |
Healthcare Sector |
# 1114 |
Overall Market |
# 4986 |
Quick Ratio Statistics |
High |
Average |
Low |
0.08 |
0.01 |
0 |
(Jun 30 2016) |
|
(Jun 30 2019) |
Cumulative Respirerx Pharmaceuticals Inc 's Quick Ratio
RSPI's Quick Ratio for the trailling 12 Months
RSPI Quick Ratio |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
(Jun 30 2022) II. Quarter |
Y / Y Current Liabilities TTM Growth |
11.25 % |
14.76 % |
18.21 % |
22.68 % |
22.5 % |
Y / Y Cash & cash equivalent TTM Growth |
34761.9 % |
-45.24 % |
-93.71 % |
-89.21 % |
-99.93 % |
Quick Ratio TTM |
0 |
0 |
0 |
0 |
0 |
Total
Ranking TTM |
# 4194
| # 4268
| # 4488
| # 4261
| # 5199
|
Seq. Current Liabilities TTM Growth |
-0.63 % |
4.76 % |
2.55 % |
4.21 % |
2.5 % |
Seq. Cash & cash equivalent TTM Growth |
5205.07 % |
56.82 % |
46.67 % |
185.71 % |
-91.67 % |
On the trailing twelve months basis In Spite of the decrease in Current Liabilities in the II Quarter 2023 to $12.21 millions, cumulative Quick Ratio | |